Antibiotic | No. (%) of non-susceptible isolates | Biofilm formation ability | p-value | |||
---|---|---|---|---|---|---|
Strong (n = 45) | Intermediate (n = 41) | Weak (n = 7) | None (n = 4) | |||
Trimethoprim/sulfamethoxazole | 14 (14.4) | 9 | 5 | 0 | 0 | 0.88 |
Imipenem | 97 (100) | 45 | 41 | 7 | 4 | – |
Meropenem | 97 (100) | 45 | 41 | 7 | 4 | – |
Levofloxacin | 2 (2.1) | 1 | 1 | 0 | 0 | 1.00 |
Minocycline | 11 (11.3) | 5 | 6 | 0 | 0 | 0.93 |
Ticarcillin/clavulanate | 59 (60.9) | 37 | 20 | 1 | 1 | 0.001 |
Tigecycline | 13 (13.4) | 9 | 4 | 0 | 0 | 0.34 |
Ceftazidime | 74 (76.3) | 40 | 26 | 4 | 0 | 0.049 |
Chloramphenicol | 38 (39.2) | 22 | 16 | 0 | 0 | 0.189 |